Top Breyanzi Manufacturers for Lymphoma Treatment
Are you on the hunt for the best Breyanzi manufacturers but feeling overwhelmed by the options? You’re not alone! With so many factories vying for your attention, finding a reliable supplier can feel like searching for a needle in a haystack. Choosing the right manufacturer can mean the difference between high-quality products and costly setbacks. The top factories not only deliver exceptional Breyanzi but also provide stellar support, ensuring your needs are met every step of the way.
Imagine partnering with a manufacturer that consistently meets your expectations and enhances your brand’s reputation. Ready to discover the top 30 Breyanzi manufacturers that can transform your sourcing strategy? Dive into our article for an insightful comparison and find your ideal partner today!
Top 22 Breyanzi Manufacturer Manufacturers
Breyanzi – Non-Hodgkin Lymphoma Treatment
Domain: breyanzi.com
Registered: 2018 ( 7 years )
Introduction: BREYANZI is a prescription medicine used to treat four types of non-Hodgkin lymphoma in adults.
Drugs.com – Prescription Medications for Lymphoma Treatment
Domain: drugs.com
Registered: 1998 ( 27 years )
Introduction: Breyanzi is a prescription medication used for the treatment of certain types of large B-cell lymphoma.
Bioprocessintl – Biopharmaceutical Manufacturing Solutions
Domain: bioprocessintl.com
Registered: 2002 ( 23 years )
Introduction: Breyanzi, a CAR T-cell therapy developed by Bristol Myers Squibb (BMS), is produced at their new cell therapy plant in Massachusetts.
Breyanzihcp – CD19-Directed T Cell Immunotherapy
Domain: breyanzihcp.com
Registered: 2018 ( 7 years )
Introduction: BREYANZI is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with large B-cell lymphoma (LBCL).
Empr – CAR T-Cell Therapy Solutions
Domain: empr.com
Registered: 1999 ( 26 years )
Introduction: Breyanzi and Abecma are CAR T-cell therapies approved for the treatment of certain types of blood cancers.
Curetoday – CAR-T Cell Therapy Solutions
Domain: curetoday.com
Registered: 2001 ( 24 years )
Introduction: Breyanzi is a CAR-T cell therapy approved for the treatment of relapsed or refractory mantle cell lymphoma (MCL).
FDA – Cancer Treatment Solutions
Domain: fda.gov
Registered: 2000 ( 25 years )
Introduction: FDA approved a new treatment for adults with relapsed or refractory large B-cell lymphoma.
Cancer Therapy Advisor – CAR T-Cell Therapies
Domain: cancertherapyadvisor.com
Registered: 2013 ( 12 years )
Introduction: Breyanzi (lisocabtagene maraleucel) and Abecma (idecabtagene vicleucel) are chimeric antigen receptor (CAR) T-cell therapies approved for treating various hematologic cancers.
GoodRx – Prescription Savings Solutions
Domain: goodrx.com
Registered: 2011 ( 14 years )
Introduction: Breyanzi is a gene therapy product used for the treatment of certain types of lymphoma, specifically large B-cell lymphoma.
Buyandbill – Oncology Solutions with BREYANZI
Domain: buyandbill.com
Registered: 2011 ( 14 years )
Introduction: BREYANZI is an Oncology drug manufactured by Bristol Myers Squibb, administered via intravenous route, and is indicated for various types of refractory and relapsed large B-cell lymphomas.
Fierce Pharma – CAR T-Cell Therapy Solutions
Domain: fiercepharma.com
Registered: 2007 ( 18 years )
Introduction: Breyanzi is a CAR T-cell therapy developed by Bristol Myers Squibb for the treatment of certain types of lymphoma.
Ema – Blood Cancer Treatment Solutions
Domain: ema.europa.eu
Registration year: Not available
Introduction: Breyanzi is a medicinal product used for the treatment of certain types of blood cancers, specifically large B-cell lymphoma.
Precision Medicine Online – CAR T-Cell Therapy Solutions
Domain: precisionmedicineonline.com
Registered: 2014 ( 11 years )
Introduction: Breyanzi is a CAR T-cell therapy developed by Bristol Myers Squibb for the treatment of certain types of blood cancers.
Biopharmadive – Cancer Cell Therapy Solutions
Domain: biopharmadive.com
Registered: 2013 ( 12 years )
Introduction: Breyanzi (liso-cel) is a cancer cell therapy approved for the treatment of late-stage lymphoma in adults.
WebMD – Health Information and Treatment Solutions
Domain: webmd.com
Registered: 1998 ( 27 years )
Introduction: Breyanzi is an intravenous medication used for the treatment of certain types of large B-cell lymphoma in adults.
Ncbi – CAR T-Cell Therapy Solutions
Domain: ncbi.nlm.nih.gov
Registered: 1997 ( 28 years )
Introduction: Breyanzi (lisocabtagene maraleucel) is a CAR T-cell therapy recommended for reimbursement for the treatment of adult patients with relapsed or refractory large B-cell lymphoma (LBCL) after 2 or more lines of systemic therapy.
Bristol Myers Squibb – Multiple Myeloma Treatment Solutions
Domain: finance.yahoo.com
Registered: 1995 ( 30 years )
Introduction: Bristol Myers Squibb’s product is a treatment for patients with multiple myeloma, specifically targeting those who have received at least one prior therapy.
Oncology Nurse Advisor – CAR T-Cell Therapy Solutions
Domain: oncologynurseadvisor.com
Registered: 2009 ( 16 years )
Introduction: Breyanzi and Abecma are CAR T-cell therapies approved for the treatment of certain types of blood cancers.
Synapse – Innovative Biopharmaceutical Solutions
Domain: synapse.inc
Registered: 2021 ( 4 years )
Introduction: Breyanzi is a prescription medicine manufactured by Bristol Myers Squibb, known generically as Lisocabtagene Maraleucel.
Hematology Advisor – CAR T-Cell Therapy Solutions
Domain: hematologyadvisor.com
Registered: 2014 ( 11 years )
Introduction: Breyanzi and Abecma are CAR T-cell therapies approved for the treatment of certain types of blood cancers.
Bristol Myers Squibb – B-cell Lymphoma Treatments
Domain: pharmaceutical-technology.com
Registered: 2000 ( 25 years )
Introduction: Bristol Myers Squibb’s product is a treatment for B-cell lymphoma, specifically targeting patients with relapsed or refractory disease.
Pharmaceutical Manufacturer – CAR T-cell Therapy Solutions
Domain: pharmaceuticalmanufacturer.media
Registered: 2021 ( 4 years )
Introduction: Breyanzi is a CAR T-cell therapy developed by Bristol Myers Squibb for the treatment of adult patients with certain types of large B-cell lymphoma.
Category Information
Breyanzi is a type of chimeric antigen receptor (CAR) T-cell therapy, specifically developed for the treatment of certain hematologic malignancies, including large B-cell lymphoma. The manufacturer of Breyanzi is Bristol Myers Squibb, a leading biopharmaceutical company known for its focus on innovative therapies in oncology, immunology, and cardiovascular diseases. The category of CAR T-cell therapies represents a significant advancement in cancer treatment, harnessing the body’s immune system to target and destroy cancer cells.
This approach not only provides new hope for patients with refractory or relapsed cancers but also exemplifies the shift towards personalized medicine. The significance of manufacturers like Bristol Myers Squibb lies in their ability to develop and bring to market these groundbreaking therapies, ultimately improving patient outcomes and expanding treatment options in oncology.
Application Information
Breyanzi, manufactured by Bristol Myers Squibb, is a chimeric antigen receptor (CAR) T-cell therapy primarily used in the treatment of certain types of lymphomas, particularly large B-cell lymphoma. Its application areas predominantly fall within the healthcare and pharmaceutical industries, particularly in oncology. One key application area is in oncology treatment, where Breyanzi provides a targeted therapeutic option for patients with relapsed or refractory large B-cell lymphoma, offering hope for those who have exhausted other treatments.
Another significant area is clinical research, where ongoing studies assess its effectiveness and safety in various patient populations, potentially expanding its use to other hematologic malignancies. Additionally, patient support services are crucial, as they help navigate the complexities of CAR T-cell therapy, including pre-treatment evaluations and post-treatment follow-ups, ensuring comprehensive care for patients.
Production Process Information
Breyazi is a type of CAR T-cell therapy used in treating certain types of blood cancers. The production process for Breyanzi involves several key stages. First, blood is collected from the patient, which contains immune cells called T cells. These cells are crucial for the therapy as they help fight cancer. Next, the T cells are sent to a specialized laboratory where they are modified using a viral vector.
This modification enables the T cells to recognize and attack cancer cells more effectively. After modification, the T cells are multiplied in the lab to produce a sufficient quantity for treatment. Finally, these engineered T cells are infused back into the patient, where they can seek out and destroy cancer cells. Overall, this complex process requires careful handling and precise techniques to ensure the safety and effectiveness of the treatment.
Related Video
Frequently Asked Questions (FAQs)
What should I consider when looking for a Breyanzi manufacturer?
When searching for a Breyanzi manufacturer, it’s essential to consider their experience and expertise in biopharmaceuticals, specifically in cell therapy. Look for manufacturers with a proven track record in producing similar products, as this can greatly impact the quality and reliability of your supply. Additionally, check for compliance with regulatory standards, such as FDA approvals and certifications, to ensure they meet industry requirements. It’s also beneficial to assess their production capacity, turnaround times, and flexibility to accommodate your needs.
How can I verify the credibility of a Breyanzi manufacturer?
To verify a manufacturer’s credibility, start by researching their reputation in the industry. Look for reviews, testimonials, and case studies from previous clients. You can also request references and reach out to other companies that have worked with them. Checking for certifications and compliance with industry regulations is crucial; make sure they have the necessary licenses and quality assurance processes in place. Additionally, consider visiting their facility if possible, as this can provide valuable insight into their operations and quality control measures.
What questions should I ask potential Breyanzi manufacturers?
When speaking with potential manufacturers, ask about their experience with Breyanzi or similar products, including their production processes and technologies used. Inquire about their quality control measures and how they handle regulatory compliance. It’s also important to discuss their capacity for scaling production, lead times, and flexibility in meeting your specific requirements. Don’t forget to ask about their customer support and communication practices, as a responsive and collaborative partner is vital for a successful relationship.
How do I compare different Breyanzi manufacturers?
To compare different Breyanzi manufacturers effectively, create a checklist of criteria that are important to you, such as experience, certifications, production capacity, and pricing. Evaluate each manufacturer against these criteria and take note of their strengths and weaknesses. It’s also helpful to request quotes and timelines for your specific needs, as this will give you a clearer picture of their capabilities and how they align with your project. Don’t hesitate to reach out for clarification on any points that may be unclear; effective communication is key.
What are the common pitfalls to avoid when choosing a Breyanzi manufacturer?
When selecting a Breyanzi manufacturer, avoid rushing the decision-making process. Take your time to thoroughly research and vet potential partners. Be wary of manufacturers that offer significantly lower prices, as this may compromise quality. Ensure you understand the terms of the contract and any hidden costs associated with production. Lastly, don’t overlook the importance of good communication; a manufacturer that is difficult to reach or unresponsive can lead to misunderstandings and delays, so prioritize finding a partner that values collaboration.